NASDAQ · Biotechnology

GeoVax Labs Inc (GOVX)

$1.81 -5.24%
17 Oversold Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$1.16+56.03%

Company profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a modified vaccinia ankara virus-like particle vaccine platform. The company is headquartered in Smyrna, Georgia.

SectorHealthcare
IndustryBiotechnology
Market cap$21.82M
P/E ratioNone
EPS$-212.16
Beta3.86
Dividend yield0.00%
52-week high$275.88
52-week low$1.84

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for GOVX

An email when GOVX closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 3:38 AM EST